Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31truetruetruetruefalsetrue2024-01-01falseProvision of pre-school childcare facilities.129172false 03092545 2024-01-01 2024-12-31 03092545 2023-01-01 2023-12-31 03092545 2024-12-31 03092545 2023-12-31 03092545 2023-01-01 03092545 c:Exceptional 2024-01-01 2024-12-31 03092545 c:Exceptional 2023-01-01 2023-12-31 03092545 d:Director1 2024-01-01 2024-12-31 03092545 d:Director2 2024-01-01 2024-12-31 03092545 d:RegisteredOffice 2024-01-01 2024-12-31 03092545 c:Buildings 2024-01-01 2024-12-31 03092545 c:Buildings 2024-12-31 03092545 c:Buildings 2023-12-31 03092545 c:Buildings c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 03092545 c:PlantMachinery 2024-01-01 2024-12-31 03092545 c:PlantMachinery 2024-12-31 03092545 c:PlantMachinery 2023-12-31 03092545 c:PlantMachinery c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 03092545 c:MotorVehicles 2024-01-01 2024-12-31 03092545 c:MotorVehicles 2024-12-31 03092545 c:MotorVehicles 2023-12-31 03092545 c:MotorVehicles c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 03092545 c:FurnitureFittings 2024-01-01 2024-12-31 03092545 c:FurnitureFittings 2024-12-31 03092545 c:FurnitureFittings 2023-12-31 03092545 c:FurnitureFittings c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 03092545 c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 03092545 c:CurrentFinancialInstruments 2024-12-31 03092545 c:CurrentFinancialInstruments 2023-12-31 03092545 c:CurrentFinancialInstruments c:WithinOneYear 2024-12-31 03092545 c:CurrentFinancialInstruments c:WithinOneYear 2023-12-31 03092545 c:ReportableOperatingSegment1 2024-01-01 2024-12-31 03092545 c:ReportableOperatingSegment1 2023-01-01 2023-12-31 03092545 c:UKTax 2024-01-01 2024-12-31 03092545 c:UKTax 2023-01-01 2023-12-31 03092545 c:ShareCapital 2024-12-31 03092545 c:ShareCapital 2023-12-31 03092545 c:ShareCapital 2023-01-01 03092545 c:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 03092545 c:RetainedEarningsAccumulatedLosses 2024-12-31 03092545 c:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 03092545 c:RetainedEarningsAccumulatedLosses 2023-12-31 03092545 c:RetainedEarningsAccumulatedLosses 2023-01-01 03092545 d:OrdinaryShareClass1 2024-01-01 2024-12-31 03092545 d:OrdinaryShareClass1 2024-12-31 03092545 d:OrdinaryShareClass1 2023-12-31 03092545 d:FRS102 2024-01-01 2024-12-31 03092545 d:Audited 2024-01-01 2024-12-31 03092545 d:FullAccounts 2024-01-01 2024-12-31 03092545 d:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 03092545 c:Subsidiary1 2024-01-01 2024-12-31 03092545 c:Subsidiary1 1 2024-01-01 2024-12-31 03092545 c:Subsidiary2 2024-01-01 2024-12-31 03092545 c:Subsidiary2 1 2024-01-01 2024-12-31 03092545 c:Subsidiary3 2024-01-01 2024-12-31 03092545 c:Subsidiary3 1 2024-01-01 2024-12-31 03092545 c:Subsidiary4 2024-01-01 2024-12-31 03092545 c:Subsidiary4 1 2024-01-01 2024-12-31 03092545 c:WithinOneYear 2024-12-31 03092545 c:WithinOneYear 2023-12-31 03092545 c:BetweenOneFiveYears 2024-12-31 03092545 c:BetweenOneFiveYears 2023-12-31 03092545 2 2024-01-01 2024-12-31 03092545 4 2024-01-01 2024-12-31 03092545 6 2024-01-01 2024-12-31 03092545 e:PoundSterling 2024-01-01 2024-12-31 03092545 c:PreviouslyStatedAmount 2023-12-31 03092545 c:Buildings c:PreviouslyStatedAmount 2023-12-31 03092545 c:Buildings c:PriorPeriodIncreaseDecrease 2023-12-31 03092545 c:PlantMachinery c:PriorPeriodIncreaseDecrease 2023-12-31 03092545 c:MotorVehicles c:PriorPeriodIncreaseDecrease 2023-12-31 03092545 c:FurnitureFittings c:PriorPeriodIncreaseDecrease 2023-12-31 03092545 c:PriorPeriodIncreaseDecrease 2023-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 03092545










KINGSCLERE NURSERIES LIMITED










ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

 
KINGSCLERE NURSERIES LIMITED
 

COMPANY INFORMATION


Directors
A Hodson 
N Hodson 




Registered number
03092545



Registered office
Old Bracknell House
Crowthorne Road North

Bracknell

Berkshire

RG12 7AR




Independent auditor
James Cowper Kreston Audit
Chartered Accountants and Statutory Auditor

201 Cumnor Hill

Cumnor

Oxford

Oxfordshire

OX2 9PJ





 
KINGSCLERE NURSERIES LIMITED
 

CONTENTS



Page
Strategic Report
 
1 - 2
Directors' Report
 
3 - 4
Independent Auditor's Report
 
5 - 7
Statement of Comprehensive Income
 
8
Balance Sheet
 
9
Statement of Changes in Equity
 
10
Notes to the Financial Statements
 
11 - 21


 
KINGSCLERE NURSERIES LIMITED
 

STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

Introduction
 
The Directors present their strategic report for the year ended 31 December 2024.
Principal activity
The principal activity of the Company is that of an operational group which provides children’s daycare facilities.

Business review
 
Combined headwinds of skills shortages, extra-inflationary input cost increases and continued high background inflation severely limited our ability to grow in 2024.  Instead we focused on optimising our operations to gain margin uplift and to consolidate our financial position.
Nonetheless a double digit fee uplift was also achieved. The revenue plan was impacted by skill shortages in the main – putting capacity constraints on nurseries which otherwise would have higher occupancy.

Principal risks and uncertainties

Tightening skills shortage throughout the sector, worsening inflation and Government policy on National Minimum and National Living wage levels resulted in continuing upward pressure on the costs of both recruitment and employment. Contingent staffing is increasingly scarce, so the business is taking steps to rebuild a bank of zero hours labour and to create a Boot Camp for the rapid development of new talent in-house in 2025.
Nonetheless we continue to recognise the value of providing good working conditions and fair salaries for all staff, and pursue a strategy of developing staff individually to enhance their careers and value in our company.  We removed some senior figures in our organisation with a view to increasing the flow of new ideas and to uplift our professionalism.  This created an immediate improvement in operational efficiency which continues to be built upon into 2025.
The Company has a strong management team which will continuously monitor the risk and challenges arising and adapt and respond quickly to challenges and changing market conditions. Increased transparency has reduced decision times while aiding consistency across the group.
Restructuring of HR and Operations created new opportunity to streamline processes and improve our operational agility – therefore bringing cost to serve per child hour down.

Financial key performance indicators
 
Turnover for the year has increased by £248,450 (2023: £590,224 increase) from £6,146,122 to £6,394,572 and increased by 4% (2023: 11% increase). Profit after tax (excluding exceptional items) for the financial year has increased by £921,440 (2023: £861,386 decrease) from £170,530 to £1,091,970 and increased by 540% (2023: 83% decrease). EBITDA (excluding exceptional items) has increased by £1,005,025 (2023: £741,330 decrease) from £235,707 to £1,240,732 reflecting an increase of 426% (2023: 76% decrease). 
The Company continues to review expenditure and inward investment and considers that the tighter practices, organisation and processes are working for the benefit of shareholders without compromising operational effectiveness or customer satisfaction.

Page 1

 
KINGSCLERE NURSERIES LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Other key performance indicators
 
The Company remains committed to improving outcomes for children while delivering affordable and reliable childcare for working families.  Our programme of reinvestment in resources and facilities creates a positive and fulfilling environment for child development and staff to work in.  By making financial commitments to our staff and play environments, we demonstrate the value that we place in the future of the business.


This report was approved by the board and signed on its behalf.





A Hodson
Director

Date: 9 June 2025

Page 2

 
KINGSCLERE NURSERIES LIMITED
 

 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The Directors present their report and the financial statements for the year ended 31 December 2024.

Results and dividends

The profit for the year, after taxation, amounted to £439,346 (2023 - loss £476,240).

Directors

The Directors who served during the year were:

A Hodson 
N Hodson 

Directors' responsibilities statement

The Directors are responsible for preparing the Strategic Report, the Directors' Report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the Directors to prepare financial statements for each financial year. Under that law the Directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the Directors are required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Future developments

We remain committed to the sector and are actively pursuing growth through acquisition. Our robust and scalable business infrastructure can support significant organisational growth. All acquisition opportunities are considered on the strength of their cultural fit as well as economic stability and potential, and in terms of what new human capital strength they would contribute to the group.

Page 3

 
KINGSCLERE NURSERIES LIMITED
 

 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024


Disclosure of information to auditor

Each of the persons who are Directors at the time when this Directors' Report is approved has confirmed that:
 
so far as the Director is aware, there is no relevant audit information of which the Company's auditor is unaware, and

the Director has taken all the steps that ought to have been taken as a Director in order to be aware of any relevant audit information and to establish that the Company's auditor is aware of that information.

Auditor

The auditor, James Cowper Kreston Auditwill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 





A Hodson
Director

Date: 9 June 2025

Page 4

 
KINGSCLERE NURSERIES LIMITED
 

 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF KINGSCLERE NURSERIES LIMITED
 

Opinion


We have audited the financial statements of Kingsclere Nurseries Limited (the 'Company') for the year ended 31 December 2024, which comprise the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Company's affairs as at 31 December 2024 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the Directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the Directors with respect to going concern are described in the relevant sections of this report.


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditor's Report thereon. The Directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Page 5

 
KINGSCLERE NURSERIES LIMITED
 

 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF KINGSCLERE NURSERIES LIMITED (CONTINUED)


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Strategic Report and the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Strategic Report and the Directors' Report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Directors' Report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of Directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Responsibilities of directors
 

As explained more fully in the Directors' Responsibilities Statement set out on page 3, the Directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.


Page 6

 
KINGSCLERE NURSERIES LIMITED
 

 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF KINGSCLERE NURSERIES LIMITED (CONTINUED)


Auditor's responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.


Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance.  
The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
The specific procedures for this engagement that we designed and performed to detect material misstatements in respect of irregularities, including fraud, were as follows:
 
Enquiry of management and those charged with governance around actual and potential litigation and claims;
Enquiry of management and those charged with governance to identify any material instances of non-compliance with laws and regulations;
Reviewing OFSTED report and correspondence to identify any material instances of non-compliance with laws and regulations;
Performing audit work to address the risk of irregularities due to management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for evidence of bias.


A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's Report.


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditor's Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.



James Pitt BA BFP FCA (Senior Statutory Auditor)
 
for and on behalf of
James Cowper Kreston Audit
Chartered Accountants and Statutory Auditor
201 Cumnor Hill
Cumnor
Oxford
Oxfordshire
OX2 9PJ

18 June 2025
Page 7

 
KINGSCLERE NURSERIES LIMITED
 

STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024

2024
2023
Note
£
£

  

Turnover
 4 
6,394,572
6,146,122

Cost of sales
  
(3,633,244)
(3,964,906)

Gross profit
  
2,761,328
2,181,216

Administrative expenses
  
(1,625,805)
(2,010,643)

Exceptional administrative expenses
 10 
(652,624)
(646,770)

Operating profit/(loss)
 5 
482,899
(476,197)

Interest receivable and similar income
 9 
2,429
-

Profit/(loss) before tax
  
485,328
(476,197)

Tax on profit/(loss)
 11 
(45,982)
(43)

Profit/(loss) for the financial year
  
439,346
(476,240)

There was no other comprehensive income for 2024 (2023: £NIL).

The notes on pages 11 to 21 form part of these financial statements.

Page 8

 
KINGSCLERE NURSERIES LIMITED
REGISTERED NUMBER: 03092545

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 12 
2,669,054
2,720,602

Investments
 13 
3,005,489
3,005,489

  
5,674,543
5,726,091

Current assets
  

Debtors: amounts falling due within one year
 14 
3,939,647
3,720,516

Cash at bank and in hand
 15 
370,235
474,145

  
4,309,882
4,194,661

Creditors: amounts falling due within one year
 16 
(3,107,290)
(3,482,963)

Net current assets
  
 
 
1,202,592
 
 
711,698

Total assets less current liabilities
  
6,877,135
6,437,789

  

Net assets
  
6,877,135
6,437,789


Capital and reserves
  

Called up share capital 
 17 
100
100

Profit and loss account
 18 
6,877,035
6,437,689

  
6,877,135
6,437,789


The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




A Hodson
Director

Date: 9 June 2025

The notes on pages 11 to 21 form part of these financial statements.

Page 9

 
KINGSCLERE NURSERIES LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024


Called up share capital
Profit and loss account
Total equity

£
£
£

At 1 January 2024
100
6,437,689
6,437,789



Profit for the year
-
439,346
439,346


At 31 December 2024
100
6,877,035
6,877,135



STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2023


Called up share capital
Profit and loss account
Total equity

£
£
£

At 1 January 2023
100
6,913,929
6,914,029



Loss for the year
-
(476,240)
(476,240)


At 31 December 2023
100
6,437,689
6,437,789


The notes on pages 11 to 21 form part of these financial statements.

Page 10

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Kingsclere Nurseries Limited (registered number 03092545) is a private limited company, limited by shares, incorporated in England and Wales. Its registered address is Old Bracknell House, Crowthorne Road North, Bracknell, RG12 7AR. The principal place of business is Cedars Day Nursery, Church Rd, Aldermaston, Berkshire RG7 4LR.
 
The principal activity of the Company is the provision of pre-school childcare facilities.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies (see note 3).

The financial statements are rounded to the nearest whole pound Sterling which is the functional and presentational currency of the company.

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A;
the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Moebius One Limited as at 31 December 2024 and these financial statements may be obtained from Old Bracknell House, Crowthorne Road North, Bracknell, RG12 7AR.

 
2.3

Exemption from preparing consolidated financial statements

The Company is a parent Company that is also a subsidiary included in the consolidated financial statements of a parent undertaking established under the law of an EEA state and is therefore exempt from the requirement to prepare consolidated financial statements under section 400 of the Companies Act 2006.

Page 11

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.4

Going concern

The Directors have prepared forecasts and projections using what they consider to be reasonable assumptions relating to the Company’s finance performance, current financial position and existing financial resources for a period of at least 12 months from the signing of the financial statements which show the Company to be a going concern.
The Group has bank borrowings subject to various covenants. The Group has prepared forecasts that show the Group will meet its financial covenants for a period of at least 12 months from the date of signing the financial statements.
The Directors are, therefore, of the opinion that the Company has the necessary resources to continue as a going concern for the foreseeable future and have therefore prepared the financial statements on a going concern basis.

 
2.5

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Revenue is recognised when the performance of the underlying services, based on attendance at the nursery, is delivered.

  
2.6

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants of a revenue nature are recognised in the Statement of comprehensive income in the same period as the related expenditure.

 
2.7

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.8

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

 
2.9

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 12

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.10

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.11

Exceptional items

Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.

 
2.12

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Land is not depreciated. Depreciation on other assets is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the following methods.

Depreciation is provided on the following basis:

Freehold property
-
2% straight line
Nursery equipment
-
10% straight line
Motor vehicles
-
25% reducing balance
Fixtures and fittings
-
20% - 50% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.13

Fixed asset investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.14

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.15

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 13

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.16

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.17

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and the amounts reported for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates. The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.
Tangible fixed assets
Tangible fixed assets are depreciated over their useful lives taking into account residual values, where appropriate. The actual lives of the assets and residual values are assessed annually and may vary depending on a number factors. Residual value assessments consider issues such as the remaining life of the asset and projected disposal values.
Fixed asset investments
At each reporting date the Directors assess whether there is any indication of impairment. Assumptions are made regarding the performance and future cash flows generated by the Company's subsidiaries. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.
Debtor recoverability
At each reporting date the Directors assess whether there is any indication of impairment. Assumptions are made regarding the performance and future cash flows generated by the debtors. A provision and irrecoverable debt loss would be recognised where the carrying amount exceeds the recoverable amount.


4.


Turnover

An analysis of turnover by class of business is as follows:


2024
2023
£
£

The provision of childcare facilities
6,394,572
6,146,122


All turnover arose within the United Kingdom.

Page 14

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Operating profit/(loss)

The operating profit/(loss) is stated after charging:

2024
2023
£
£

Other operating lease rentals
57,244
177,821

Depreciation
105,209
87,461

Define contribution pension cost
63,539
62,225


6.


Auditor's remuneration

During the year, the Company obtained the following services from the Company's auditor:


2024
2023
£
£

Fees payable to the Company's auditor for the audit of the Company's financial statements
13,310
12,100


7.


Employees

Staff costs, including Directors' remuneration, were as follows:


2024
2023
£
£

Wages and salaries
3,455,422
3,628,953

Social security costs
314,426
312,429

Defined contribution pension cost
63,539
62,225

Exceptional Items (see note 10)
652,624
646,770

4,486,011
4,650,377


The average monthly number of employees, including the Directors, during the year was as follows:


        2024
        2023
            No.
            No.







Nursery staff and administration
129
172

Page 15

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

8.


Directors' remuneration

2024
2023
£
£

Directors' emoluments
128,000
128,000

Defined contribution pension cost
9,600
9,600

Directors' bonuses classed as exceptional (see note 10)
573,483
573,825

711,083
711,425


During the year retirement benefits were accruing to 1 Director (2023 - 1) in respect of defined contribution pension schemes.

Only one director is remunerated through the Company and the information disclosed in this note relates to the highest paid director.


9.


Interest receivable

2024
2023
£
£


Bank interest receivable
2,429
-


10.


Exceptional items

2024
2023
£
£


Directors' bonus - Gross
573,483
573,825

Directors' bonus - Employers NI
79,141
72,945

652,624
646,770

During the 2024 and 2023, significant bonuses were paid to a director and are recognised within administrative expenses. This is considered to be of such significance to the Company's financial statements that this has been disclosed separately on the Statement of Comprehensive Income. 

Page 16

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

11.


Taxation


2024
2023
£
£

Corporation tax


Current tax on profits for the year
45,982
43


45,982
43


Total current tax
45,982
43

Factors affecting tax charge for the year

The tax assessed for the year is lower than (2023 - higher than) the standard rate of corporation tax in the UK of 25% (2023 - 23.52%). The differences are explained below:

2024
2023
£
£


Profit/(loss) on ordinary activities before tax
485,328
(476,197)


Profit/(loss) on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2023 - 23.52%)
92,212
(112,002)

Effects of:


Expenses not deductible for tax purposes
2,724
49,731

Capital allowances for year in excess of depreciation
17,014
10,306

Movement in deferred tax not recognised
(74,284)
(109,559)

Adjustments to tax charge in respect of prior periods
21,530
(4,664)

Short-term timing difference leading to an increase (decrease) in taxation
-
6,484

Group relief
(13,214)
159,747

Total tax (credit)/charge for the year
45,982
43


Factors that may affect future tax charges

There are no factors that may affect future tax charges.

Page 17

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

12.


Tangible fixed assets





Freehold property
Plant and machinery
Motor vehicles
Fixtures and fittings
Total

£
£
£
£
£



Cost or valuation


At 1 January 2024 (as previously stated)
2,121,360
116,938
37,833
624,152
2,900,283


Prior Year Adjustment (see note 19)
1,125,000
-
-
-
1,125,000


At 1 January 2024 (as restated)
3,246,360
116,938
37,833
624,152
4,025,283


Additions
3,180
-
37,035
13,446
53,661



At 31 December 2024

3,249,540
116,938
74,868
637,598
4,078,944



Depreciation


At 1 January 2024
589,971
116,938
31,258
566,514
1,304,681


Charge for the year
64,169
-
6,041
34,999
105,209



At 31 December 2024

654,140
116,938
37,299
601,513
1,409,890



Net book value



At 31 December 2024
2,595,400
-
37,569
36,085
2,669,054



At 31 December 2023 (as restated)
2,656,389
-
6,575
57,638
2,720,602

Page 18

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

13.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2024 (as previously stated)
4,130,489


Prior Year Adjustment (see note 19)

(1,125,000)


At 1 January 2024 (as restated)
3,005,489



At 31 December 2024
3,005,489





Subsidiary undertakings


The following were subsidiary undertakings of the Company:

Name

Class of shares

Holding

Yellow Brick House Nursery Limited
Ordinary
100%
Yellow Brick Nursery Limited
Ordinary
100%
H A B Kindergartens Limited
Ordinary
100%
Saltway Day Nursery Limited
Ordinary
100%

The registered office of each company is the same as that of Kingsclere Nurseries Limited as disclosed on the Company Information page.


14.


Debtors

2024
2023
£
£


Trade debtors
68,917
58,597

Amounts owed by group undertakings
3,702,372
3,415,499

Other debtors
61,231
180,784

Prepayments and accrued income
107,127
65,636

3,939,647
3,720,516


 Amounts owed by group undertakings are repayable on demand, unsecured and non-interest bearing.

Page 19

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

15.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
370,235
474,145



16.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
23,189
141,729

Amounts owed to group undertakings
2,524,926
2,776,861

Corporation tax
53,571
-

Other taxation and social security
-
5,068

Other creditors
46,617
51,647

Accruals and deferred income
458,987
507,658

3,107,290
3,482,963


Amounts owed to group undertakings are repayable on demand and non-interest bearing.


17.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100 (2023 - 100) Ordinary shares of £1.00 each
100
100



18.


Reserves

Profit and loss account

The profit and loss account includes cumulative profits available for distribution.


19.


Prior year adjustment

During the year ended 31 December 2024, management identified an amount of £1,125,000 that related to freehold property but had incorrectly been included within fixed asset investments. The effect of this adjustment on the year ended 31 December 2023 is to decrease fixed asset investments and increase tangible fixed assets by £1,125,000. There is no impact on the reported profit.


20.


Contingent liabilities

The Company is party to a guarantee given to Royal Bank of Scotland PLC in respect of group borrowings. These borrowings are held entirely within Moebius Two Limited, a fellow group company.

Page 20

 
KINGSCLERE NURSERIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

21.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. Contributions totaling £9,477 (2023: £17,221) were payable to the fund at the balance sheet date and are included in other creditors.


22.


Commitments under operating leases

At 31 December 2024 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2024
2023
£
£


Not later than 1 year
24,410
25,638

Later than 1 year and not later than 5 years
-
410

24,410
26,048


23.


Related party transactions

The Company is exempt under Paragraph 33.1A of FRS 102 from disclosing related party transactions with entities that are part of the group headed by Moebius One Limited, where 100% of the voting rights are controlled within the group.


24.


Controlling party

The ultimate parent company at the balance sheet date was Moebius One Limited, a company incorporated in England and Wales.
The parent of the smallest and largest group for which group accounts including Kingsclere Nurseries Limited are drawn up is Moebius One Limited. Copies of these accounts may be obtained from their registered office.

Page 21